These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 9227442
21. Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect. Satoh N, Ogawa Y, Usui T, Tagami T, Kono S, Uesugi H, Sugiyama H, Sugawara A, Yamada K, Shimatsu A, Kuzuya H, Nakao K. Diabetes Care; 2003 Sep; 26(9):2493-9. PubMed ID: 12941708 [Abstract] [Full Text] [Related]
22. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Ikeda H, Taketomi S, Sugiyama Y, Shimura Y, Sohda T, Meguro K, Fujita T. Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):156-62. PubMed ID: 2334455 [Abstract] [Full Text] [Related]
24. Expression of ICAM-1 on glomeruli is associated with progression of diabetic nephropathy in a genetically obese diabetic rat, Wistar fatty. Matsui H, Suzuki M, Tsukuda R, Iida K, Miyasaka M, Ikeda H. Diabetes Res Clin Pract; 1996 Apr; 32(1-2):1-9. PubMed ID: 8803476 [Abstract] [Full Text] [Related]
28. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy. Katavetin P, Eiam-Ong S, Suwanwalaikorn S. J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002 [Abstract] [Full Text] [Related]
31. Effects of KIOM-79 on hyperglycemia and diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats. Kim CS, Sohn EJ, Kim YS, Jung DH, Jang DS, Lee YM, Kim DH, Kim JS. J Ethnopharmacol; 2007 May 04; 111(2):240-7. PubMed ID: 17194556 [Abstract] [Full Text] [Related]
32. Rosiglitazone, a peroxisome proliferator-activated receptor γ stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity. El-Bassossy HM, Abo-Warda SM, Fahmy A. Clin Exp Pharmacol Physiol; 2012 Aug 04; 39(8):643-9. PubMed ID: 22594672 [Abstract] [Full Text] [Related]
34. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice. Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Noguchi H, Taiji M. Diabetes Obes Metab; 2007 Nov 04; 9(6):879-88. PubMed ID: 17924870 [Abstract] [Full Text] [Related]
39. Pioglitazone improves left ventricular diastolic function and decreases collagen accumulation in prediabetic stage of a type II diabetic rat. Tsuji T, Mizushige K, Noma T, Murakami K, Ohmori K, Miyatake A, Kohno M. J Cardiovasc Pharmacol; 2001 Dec 04; 38(6):868-74. PubMed ID: 11707690 [Abstract] [Full Text] [Related]
40. A lack of synergistic interaction between insulin and pioglitazone on reactivity of rat aorta from chronically high dose insulin-treated diabetic rats. Sahilli M, Irat AM, Işik AC, Karasu C, Ozansoy G, Ari N. Gen Physiol Biophys; 2007 Mar 04; 26(1):48-55. PubMed ID: 17579254 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]